Xilio Therapeutics (XLO) : 3-year performance

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 73
• Founded in 2016 
• Headquartered in Waltham, Massachusetts
• https://xiliotx.com

Ticker: XLO

October 22, 2021 : initial public offering of 7,353,000 shares of its common stock at a price to the public of $16.00 per share. 

 

 

 

IPOs this week : Nov. 15 - 19, 2021 (wk 46)

IPOs expected to price

• Braze (NASDAQ:BRZE), UserTesting (NYSE:USER), Iris Energy (NASDAQ:IREN), Sono Group (NASDAQ:SEV) on November 17, as well as KC Holdco (NYSE:KLC) and Sweetgreen (NYSE:SG) on November 18. 

Of the bunch, Sono Group is capturing the most attention. The parent company for Sono Motors describes itself as being on a pioneering mission to accelerate the revolution of mobility by making every vehicle solar. The company's Sion solar electric vehicle is expected to be the first of its kind and more than 16K reservations with advance payments have been made. The vehicle will be produced through contract manufacturing with customer deliveries expected to begin in the first half of 2023. Sono Motors (SEV) believes that SEVs will be the next big wave in e-mobility and calls combustion engines a thing of the past. The company wants to take the solar concept to trucks, trailers and buses.

IPO quiet period expirations

• Vita Coco Company (NASDAQ:COCO), Enfusion (NYSE:ENFN), Portillo's (NASDAQ:PTLO), P10 (NYSE:PX), Runway Growth Finance (NASDAQ:RWAY), Stronghold Digital Mining (NASDAQ:SDIG) and Ventyx (VYTX) on November 15. 
• Aris Water Solutions (NYSE:ARIS), Xilio Therapeutics (NASDAQ:XLO) and Minerva Surgical (NASDAQ:UTRS) on November 16.

IPO lockup expirations

• Jiuzi Holdings (NASDAQ:JZXN), Oatly Group (NASDAQ:OTLY), Procore Technologies (NYSE:PCOR) and Virpax Pharmaceuticals (NASDAQ:VRPX).